COVID-19: Difference between revisions
Gerald Chi- (talk | contribs) |
Gerald Chi- (talk | contribs) |
||
Line 25: | Line 25: | ||
==[[COVID-19 natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[COVID-19 natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
[[COVID-19 Cardiovascular Complications|Cardiovascular Complications]] | [[COVID-19 Cardiovascular Complications|Cardiovascular Complications]] | [[COVID-19 Hematologic Complications|Hematologic Complications]] | ||
==Diagnosis== | ==Diagnosis== |
Revision as of 16:44, 23 June 2020
COVID-19 Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
COVID-19 On the Web |
American Roentgen Ray Society Images of COVID-19 |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]; Syed Hassan A. Kazmi BSc, MD [3]
Synonyms and keywords:; Novel coronavirus, covid-19, COVID-19, Wuhan coronavirus
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating COVID-19 from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Cardiovascular Complications | Hematologic Complications
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies